A new study published in the Annals of Internal Medicine reported that age-adjusted lung cancer mortality in the United States is estimated to decrease by 79 percent between 2015 and 2065. However, the authors noted, millions of lung cancer deaths are still projected during that time, making it especially important to emphasize screening in the years ahead.
Read the full article here.
Lung cancer screenings are instrumental in early detection, and ultimately the successful treatment of lung cancer. HealthMyne makes it easier for healthcare facilities to track patients throughout the screening process and ensure they have been followed up with appropriately. Learn more about the Quantitative Imaging Decision Support (QIDS)™ platform for lung cancer screening programs here.